Leveraging preclinical models for the development of Alzheimer disease therapeutics
Year: 2020
Type: review
Source: Nature Reviews Drug Discovery
Institution: Denali Therapeutics (United States)
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3015437269
